Mike Bruninghaus is currently a Principal Quality Engineer at Sanofi, a position they have held since 2025. Previously, they served as Associate Director of Quality Engineering Validation at CRISPR Therapeutics from 2023 to 2024, and earlier held various roles at Sanofi, showcasing expertise in quality assurance and engineering. Mike earned a Bachelor of Science in Biotechnology from Worcester Polytechnic Institute in 2007. Their diverse experience in quality engineering and compliance spans over a decade in the biopharmaceutical industry.
This person is not in any teams
This person is not in any offices